226 references to research demonstrating cancer reversal & recovery successes. Successful treatments include repurposed drugs, DMSO, CDS, integrative therapies, nutrients, essential oils.
References to published research, organized by subject and date: 51 anti-parasitic references + 152 references for other treatments + 23 methylene blue references (research & warning)
Contents
Searching
Anti-Parasitics
More Successful Treatments
Research & Warning: Methylene Blue (Synthetic)
Cancer Reversal & Recovery Successes
Free Reference Guide
For Wellness Providers & Educators: Boost Your Impact — Premium Resources Just a Click Away from $19
Searching
To search for a type of cancer or a particular therapy:
You can use the “find” function which is available for most programs and apps. Select ctrl-F on keyboard for a “find” box to appear on your screen. Type in the phrase you’re looking for.
The box will display the number of times that phrase is found on the page (as in the screenshot below). With your cursor in the find box, press enter to jump to the next instance of the phrase. To remove the find box, select “X” on the box.
Anti-Parasitics
Ivermectin: Antitumor Effects, Promotes Cancer Death, Nontoxic to Normal Cells, Reverses Multidrug Resistance
Ivermectin effectively suppresses the proliferation and metastasis of cancer cells and promotes cancer cell death at doses that are nontoxic to normal cells. Ivermectin shows excellent efficacy against conventional chemotherapy drug-resistant cancer cells and reverses multidrug resistance… Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells… Ivermectin promotes programmed cancer cell death, including apoptosis, autophagy and pyroptosis… ,Ivermectin can also inhibit tumor stem cells.
Pharmacological Research, 2021
Studies demonstrate that Ivermectin inhibits glucose uptake by downregulating GLUT1 transporters and hexokinase II, key enzymes in the glycolytic cascade. This starves cancer cells of their primary fuel, inducing energy stress and apoptosis. Additionally, Ivermectin disrupts microtubule dynamics halting mitotic spindle formation in rapidly dividing cells. These activities do not materially impact healthy cells that rely on oxygen for its primary fuel, and as they are not rapidly dividing, disrupting the microtubular network does not impact them. (The opposite of chemotherapy, which indiscriminately destroys all cells, and ultimately poisons the patient.) … Fenbendazole… complements Ivermectin by targeting overlapping yet distinct metabolic vulnerabilities… Unlike Ivermectin, Fenbendazole also impairs proteasomal function, amplifying cellular stress and triggering p53-mediated apoptosis in colorectal and lung cancer models. Fenbendazole’s efficacy perfectly aligns with Warburg’s thesis in its capacity to exploit cancer’s glycolytic (sugar) addiction; by curtailing glucose availability, Fenbendazole forces malignant cells into a metabolic cul-de-sac, where compensatory mechanisms falter. Preclinical studies highlight its efficacy against drug-resistant tumors, suggesting a role in overcoming the cancer stem cell driven relapses that plague conventional therapies… Allulose, a rare sugar found naturally in figs is a C-3 epimer of fructose, emerges as a novel adjunct in this metabolic triad… Research illuminates its anticancer potential, aligning with Warburg’s emphasis on glucose deprivation… Mechanistically, allulose inhibits intestinal glucose absorption and promotes urinary excretion, lowering systemic glucose levels without triggering insulin spikes. This metabolic rerouting disrupts the fuel supply to cancer cells, amplifying the effects of both Ivermectin and Fenbendazole.
Apr 26, 2026 — Cancer Breakthrough Suppressed? New Human Observational Data Reveals 84% Success Rate Using Widely Available Anti-Infective Combination Therapy. “… promising findings from a new human observational study regarding the use of a combination therapy of ivermectin and mebendazole for cancer patients… When asked why such potential breakthroughs are not being pursued by major cancer centers, Dr. McCullough pointed to perverse financial incentives. He explained that large cancer centers often rely on “book and bill” models, which prioritize the use of high-cost, proprietary chemotherapy drugs that provide significant profit margins. Consequently, there is no institutional incentive to research or utilize low-cost, readily available generics, despite their potential efficacy.” — Dr. Peter A. McCullough MD, MPH link
Apr 19, 2026 — Major Antineoplastic Mechanisms of Combination Ivermectin-Mebendazole — Peter A. McCullough, MD, MPH 8-min video
Apr 15, 2026 — 84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months — Nicolas Hulscher, MPH 6-min video
Jan 9, 2026 — IVERMECTIN in Lung Cancer - How Ivermectin kills Lung Cancer cells - 2025 Paper (UAE, Egypt, Saudi) — William Makis link
Aug 18, 2025 — NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients: Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission — without chemotherapy. — Nicolas Hulscher MPH link
Aug 16, 2025 — BREAKING NEWS: Our FENBENDAZOLE in Cancer Paper has been Published! Largest cancer patient publication since the 2021 Stanford Paper - three Stage 4 Cancer patients take Fenbendazole now in remission — Dr. William Makis MD link
August 2025 — Targeting EGFR/PI3K/AKT/mTOR and Bax/Bcl-2/caspase3 pathways with ivermectin mediates its anticancer effects against urethane-induced non-small cell lung cancer in BALB/c mice; “Ivermectin showed crucial cytotoxic, anti-proliferative and anti-angiogenic impact. Ivermectin ameliorated lung cancer via reduction of EGFR/PI3K/AKT/m-TOR/VEGF axis. Ivermectin is repurposed as a potential therapeutic drug for lung cancer treatment.” — Marina N. Malak et al, Tissue and Cell link
Jun 15, 2025 — Scientists Announce Major Breakthrough as Ivermectin Nanoparticles Destroy Brain Cancer Cells — Frank Bergman, SLAY link
May 26, 2025 — Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients — Dr. William Makis et al, Case Reports in Oncology link
Apr 22, 2025 — NEW STUDY – Ivermectin Shows Striking Anticancer Potential and Remarkable Safety: Largest review to date of ivermectin use in cancer patients finds no safety concerns, promising anecdotal reports, and strong preclinical evidence of tumor suppression. — Nicolas Hulscher MPH link
Apr 9, 2025 — A Review of Ivermectin Use in Cancer Patients: Is It Time to Repurpose Ivermectin in Cancer Treatment? — Lai Yuwen et al, Acta Poloniae Pharmaceutica link
Mar 31, 2025 — How to Block Cancer Stem Cells: A few specific options with more to follow; “Based on cumulative mechanistic, preclinical, and clinical evidence from the Cancer Care monograph and other sources, the most robust biochemical CSC-targeting agents to date are: Metformin, Curcumin, Disulfiram, Ivermectin, Green Tea Extract (EGCG), and Berberine. However, we should also consider the safety profile of these agents. My understanding is that disulfiram can have significant and severe side effects. The other treatments, especially curcumin and ivermectin, are safe. Some sources suggest that curcumin is not easily absorbed and should be combined with piperine (black pepper extract). We should also always check for possible interactions with any other medications or supplementation we are using.” — Justin Smith link
Jan 15, 2025 — Do Ivermectin and Mebendazole help against cancer? Research in different cancers. — Dr. Igor Atabekov (YouTube) 10-min video
Jan 12, 2025— BOMBSHELL CURE For Pfizer’s COVID “Vaccine” Integration Into The Human Genome; “The latest research findings support what this Substack has been theorizing for the last few years regarding the miraculous repurposed compounds Ivermectin and Fenbendazole.” — 2nd Smartest Guy in the World link
Dec 3, 2024 — Groundbreaking Study on Ivermectin and Fenbendazole in Cancer Treatment; “The research reveals the combined effects of ivermectin, fenbendazole, and complementary compounds in addressing cancer at multiple levels. While traditionally known as antiparasitic drugs, ivermectin and fenbendazole, when used together, showed potential to modulate cancer pathways and support the body’s natural healing mechanisms. Key findings from the study: 1. Immune System Modulation… 2. Cellular Repair… 3. Anti-Cancer Activity… These effects were further amplified by the addition of Vitamin E, curcumin, and CBD, which are known for their anti-inflammatory, antioxidant, and immune supporting properties. This synergy highlights the importance of combining multiple therapeutic elements to address the complexities of cancer biology. Read the full study here to explore the detailed findings.” — Internal Healing & Wellness (Dr. Khan MD, Functional Medicine Doctor in The Woodlands) link
Nov 5, 2024 — Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage — Ning Fan et al, Anti-Cancer Agents link
Oct 14, 2024 — New Cancer Treatment Protocol Featuring ‘Horse Dewormer’ Ivermectin, ‘Dog Dewormer’ Fenbendazole, and Mebendazole Passes Peer Review, Marking Potential Breakthrough in Therapy; “According to the publication, ivermectin, fenbendazole, and mebendazole each exhibit anticancer properties through distinct yet complementary mechanisms. Ivermectin, an antiparasitic agent, induces apoptosis in cancer cells by modulating mitochondrial function and inhibiting critical pathways such as glycolysis. It has shown significant efficacy in shrinking tumor volumes in various cancer types, including pancreatic cancer, when used alone or in combination with other agents. Fenbendazole and mebendazole, originally used as veterinary antiparasitic agents, have shown promise as anticancer agents by disrupting microtubule formation, inhibiting glucose metabolism, and inducing apoptosis specifically in cancer cells. Both drugs have been demonstrated to reduce tumor growth and improve survival in preclinical cancer models, often surpassing traditional chemotherapy in efficacy.” — Jim Hoft, Gateway Pundit link
Sep 19, 2024 — Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol; “Based on our review of the scientific literature, the following protocol combining orthomolecules, drugs and additional therapies for targeting the mitochondrial-stem cell connection (MSCC) in cancer treatment is proposed: Intravenous Vitamin C… Oral Vitamin D… Zinc… Ivermectin… Benzimidazoles and DON… Dietary Interventions… Additional Therapeutics.” [Dosage considerations included in paper.] — Ilyes Baghli et al, Journal of Orthomolecular Medicine link
September 2024 — Oral Fenbendazole for Cancer Therapy in Humans and Animals — Jolie Nguyen et al, Anticancer Research link
Mar 20, 2024 — Lipid-Restricted Culture Media Reveal Unexpected Cancer Cell Sensitivities; “Fenretinide and ivermectin [are] small molecules whose cytotoxicity is greatly enhanced in lipid-restricted media formulations. The mechanism of action studies indicates that ivermectin-induced cell death involves oxidative stress… Notably, both fenretinide and ivermectin have previously demonstrated in vivo anticancer efficacy despite their low cytotoxicity [cell toxicity] under typical cell culture conditions.” — Ralson B. Goldfarb et al, ACS Chemical Biology link
Mar 12, 2024 — Ivermectin: A Multifaceted Drug With a Potential Beyond Anti-parasitic Therapy; “Ivermectin is a derivative of avermectin originally used to treat parasitic infections. Emerging literature has suggested that its role goes beyond this and may help treat inflammatory conditions, viral infections, and cancers.” — Baneet Kaur et al, Cureus link
Jan 26, 2024 — Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20 — Iram Fatima et al, British Journal of Cancer link
Jan 24, 2024 — Gene signatures to therapeutics: Assessing the potential of ivermectin against translocation multiple myeloma; “Ivermectin showed strong binding affinity to all 10 identified targets… Ivermectin inhibited translocation multiple myeloma cell growth… and induced multiple myeloma cell apoptosis in vitro. Furthermore, ivermectin increased reactive oxygen species accumulation and altered the mitochondrial membrane potential in translocation multiple myeloma cells.” — Yang Song et al, World Journal of Clinical Oncology link
Oct 14, 2023 — Antiparasitic Drugs Killing Cancer? How does it work? Can it be used by cancer patients?; “A number of drugs against parasites (artemisinin, ivermectin, chloroquine, hydroxychloroquine, albendazole, mebendazole, etc.), which have long been used in humans, have attracted the attention of scientists in recent years. It has been observed that they are also able to attack cancer cells, reducing the resistance of tumors. In this video we will look at what is currently known about the use of antiparasitic drugs against cancer. — Dr. Igor Atabekov, Oncologist 10-min video
Oct 10, 2023 — Ivermectin as a potential therapeutic strategy for glioma [tumor on brain or spinal cord]; “This review seeks to provide an overview of the underlying mechanisms that enable ivermectin’s capacity to suppress glioma. Furthermore, it aims to elucidate the challenges and prospects associated with utilizing ivermectin as a new anticancer agent.” — Xing Hu et al, Journal of Neuroscience Research link
Oct 3, 2023 — Ivermectin: Wonderdrug; “It has profound anti-cancer properties. How profound? Well, consider the following: Overcomes cancer cell resistance to chemotherapy (read here). Inhibits a protein (PAK1) essential for the growth of more than 70% of all cancers (read here). Multiple mechanisms of action against breast cancer (read here).” — Dr. Michael Turner MD link
Sep 23, 2023 — Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells — Man-Yuan Li et al, Cancer Chemotherapy and Pharmacology link
Aug 25, 2023 — Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy “Ivermectin preclinical/clinical anticancer activity: KPNB1-dependent anti-proliferative and pro-apoptotic effects in epithelial ovarian carcinoma and chronic myeloid leukaemia cell lines. Blocked nuclear import of HIF-1a, thereby downregulating hypoxia-induced tumorigenic transcriptional responses.” — Stella Newell et al, IUBMB Life link
Jun 14, 2023 — Ivermectin May Defeat Cancer and Other Common Chronic Diseases of Aging: If you think Big Pharma had good reasons to censor ivermectin during Covid-19 how about now when we know it is likely effective against all chronic diseases associated with aging? — Marian Laderoute PhD (Immunology) link
Jan 10, 2023 — Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers — Daniela Meco et al, International Journal of Molecular Sciences link
May 12, 2023 — Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway — Angela Samy et al, Journal of Cancer Research and Clinical Oncology link
Aug 25, 2022 — Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction — Da Eun Lee et al, Frontiers in Pharmacology link
Jun 15, 2022 — Abstract 2320: Ivermectin suppresses pancreatic cancer via mitochondria dysfunction — Daeun Lee et al, American Association for Cancer Research link
Aug 12, 2021 — Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth — Shican Zhou et al, Frontiers in Pharmacology link
Aug 3, 2021 — Johns Hopkins Study: Anti-Parasitic Drug Slows Pancreatic Cancer in Mice; “In a study published in the journal Oncotarget on July 6, Gregory Riggins, M.D., Ph.D., professor of neurosurgery and oncology at the Johns Hopkins University School of Medicine, and his team used two different mouse models to determine that the anti-parasitic drug mebendazole could slow or stop the growth and spread of both early and late-stage pancreatic cancer.” — Johns Hopkins Medicine link
Jul 6, 2021 — Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer — Tara Williamson et al, Oncotarget link
Jun 30, 2021 — Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update; “Two clinical reports for albendazole and 2 case reports for mebendazole have revealed promising effects of these drugs in human patients having variable types of cancers. However, because of the toxicity of albendazole… mebendazole is currently more popularly used than albendazole in anti-cancer clinical trials.” — Jony-Yil Chai et al, The Korean Journal of Parasitology link
June 2021 — Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update; “It is of particular note that albendazole and mebendazole have been repositioned as promising anti-cancer drugs. These drugs have been shown to be active in vitro and in vivo (animals) against liver, lung, ovary, prostate, colorectal, breast, head and neck cancers, and melanoma… However, because of the toxicity of albendazole… if high doses are used for a prolonged time, mebendazole is currently more popularly used than albendazole in anti-cancer clinical trials.” — Jong-Yil Chai et al, The Korean Journal of Parasitology link
Apr 29, 2021 — Repositioning of Antiparasitic Drugs for Tumor Treatment; “Based on the similarities between parasitic diseases and cancer, recent studies aimed to investigate the efficacy of existing antiparasitic drugs in cancer…. These drugs regulate tumor growth via multiple targets, pathways, and modes of action. These antiparasitic drugs are good candidates for comprehensive, in-depth analyses of tumor occurrence and development.” — Yan-Qi Li et al, Frontiers in Oncology link
Mar 18, 2021 — Albendazole exerts antiproliferative effects on prostate cancer cells by inducing reactive oxygen species generation — Ukjin Kim et al, Oncology Letters link
Mar 2, 2021 — Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer — Dobrin Draganov et al, NPJ Breast Cancer link
Feb 10, 2021 — Fenbendazole Enhancing Anti-Tumor Effect: A Case Series — Ryan S. Chiang et al, Clinical Oncology: Case Reports link
January 2021 — Ivermectin, a potential anticancer drug derived from an antiparasitic drug; “Ivermectin effectively suppresses the proliferation and metastasis of cancer cells and promotes cancer cell death at doses that are nontoxic to normal cells. Ivermectin shows excellent efficacy against conventional chemotherapy drug-resistant cancer cells and reverses multidrug resistance.” — Mingyang Tang et al, Pharmacological Research link
Nov 12, 2020 — Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial — Gary L. Gallia et al, Neuro-Oncology Advances link
Jan 21, 2020 — Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin — Jian Liu et al, Drug Design, Development and Therapy link
Aug 31, 2019 — Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature; “Several in vitro studies suggest that mebendazole (MBZ) inhibits a wide range of factors involved in tumor progression… MBZ not only exhibits direct cytotoxic activity, but also synergizes with ionizing radiations and different chemotherapeutic agents and stimulates antitumoral immune response. In vivo, MBZ treatment… led to the reduction or complete arrest of tumor growth, marked decrease of metastatic spread, and improvement of survival.” — Andrea Emanuele et al, Cancers link
Jun 18, 2019 — Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway; “Ivermectin significantly enhanced the anti-cancer efficacy of chemotherapeutic drugs to tumor cells, especially in the drug-resistant cells.” — Lu Jiang et al, Journal of Experimental & Clinical Cancer Research link
Aug 12, 2018 — Cytotoxic Effect of Albendazole on the Breast Cancer and Melanoma Cell Lines; “Albendazole significantly reduced the viability of MCF7 [a “breast cancer cell line”]… In addition, this effect on B16F10 [“the melanoma cell line”] in all Albendazole concentration levels was significant.” — Spideh Javdan et al, Zahedan Journal of Research in Medical Sciences link
Apr 20, 2017 — Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer; “Albendazole treatment resulted in apoptosis, inhibition of cell migration, cell cycle arrest in the G2/M phase and altered tubulin distribution. Normal control cells were not measurably affected by any dose tested. This study indicates that albendazole acts to inhibit the proliferation of human papillomavirus-negative HNSCC cell lines.” — Farhad Ghasemi et al, Oncotarget link
Sep 22, 2016 — Albendazole as a promising molecule for tumor control — L.S.E.P.W. Castro et al, Redox Biology link
Feb 10, 2011 — Ivermectin, ‘Wonder Drug’ from Japan: The Human Use Perspective; “Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world’s most devastating and disfiguring diseases which have plagued the world’s poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found. This paper looks in depth at the events surrounding ivermectin’s passage from being a huge success in Animal Health into its widespread use in humans, a development which has led many to describe it as a ‘wonder’ drug.” — Andry Crump & Satoshi Omura, Proceedings of the Japan Academy link
More Successful Treatments
Jan 24, 2026 — Exclusive: The Cancer Protocol Big Pharma Tried to Bury. Doctors gave him 60 days to live. That was 51 years ago. What Rick Hill shares in this interview will stay with you forever. — The Vigilant Fox link
Dec 21, 2025 — Vitamin D Could Prevent 30,000 Cancer Deaths Per Year in Germany Alone: Over 900 studies show anti-cancer activity of vitamin D across most cancer types, and randomized controlled trials demonstrate a ~13% reduction in cancer mortality. — Nicolas Hulscher MPH link
Aug 6, 2025 — Fermented Stevia Extract Kills Pancreatic Cancer Cells in Lab Tests: Fermentation boosts stevia’s ability to target cancer cells while leaving healthy ones unharmed — George Citroner, The Epoch Times link
Aug 5, 2025 — The Surprising Health Benefits of Baking Soda; “According to animal studies, baking soda’s alkalinity may contribute to slowing down cancer growth by creating a less favorable environment for tumors.” — Dr. Joseph Mercola link
Aug 2, 2025 — Laetrile: How the Medical Mafia Buried a Cheap, Natural Cancer Remedy; “Laetrile… is the most famous of the nitrilosides - a class of natural compounds found abundantly in apricot kernels, bitter almonds, and over 1,200 other seeds and plants… Laetrile's remarkable specificity stems from fundamental differences in cancer cell metabolism that modern biochemistry has now decoded. At the molecular level, cancer cells overexpress the enzyme beta-glucosidase by 100-3,000x compared to healthy cells, as demonstrated in recent research. This enzyme cleaves amygdalin into benzaldehyde (a natural compound with demonstrated anti-angiogenic properties) and hydrogen cyanide, which creates localized cytotoxic (“cell killing”) effects precisely where tumors thrive. What makes this system truly amazing is that healthy cells are protected by rhodanese, an enzyme that converts released cyanide into harmless thiocyanate for safe excretion, as detailed in NIH metabolic studies.” — The Truth About Cancer link
Jul 22, 2025 — Cancer free after mushroom: Success treating kidney/renal cancer with mushroom. — Dr. John Campbell, YouTube testimonial
Jul 18, 2025 — Stevia leaf extract has potential as anticancer treatment, researchers find — Hiroshima University, EurekAlert! link
Jun 24, 2025 — The Science-Backed Health Revolution: 50+ Evidence-Based Benefits of Whey Protein: How 150 Peer-Reviewed Studies Reveal One of Nature's Most Powerful Therapeutic Foods— Sayer Ji link
May 25, 2025 — BREAST CANCER SKIN INVOLVEMENT: Topical DMSO + Castor Oil + Ivermectin or Fenbendazole Applications – a brand new concept that could be revolutionary — Dr. William Makis MD link
Apr 28, 2025 — Stevia Leaf Extract Fermented with Plant-Derived Lactobacillus plantarum SN13T Displays Anticancer Activity to Pancreatic Cancer PANC-1 Cell Line — Rentao Zhang et al, International Journal of Molecular Sciences link
Aug 16, 2025 — Ultraviolet Blood Irradiation: The Complete Evidence and Clinical Guide by A Midwestern Doctor — Lies are Unbekoming link
Apr 15, 2025 — Gut Microbes Release Cancer-fighting Bile Acids that Block Hormone Signals; “Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators… Primary bile acids are produced by the liver and released into the gut, where diverse groups of bacteria work together to modify their chemical structures.” — Weill Cornell Medicine link
Apr 15, 2025 — Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity; “A subset of these microbiota-derived bile acids (BAs) are potent antagonists of the human androgen receptor (hAR). They inhibit AR-related gene expression and are human-relevant. As a proof-of-principle, we demonstrate that one of these BAs suppresses tumor progression and potentiates the efficacy of anti-PD-1 treatment in an AR-dependent manner.” — Wen-Bing Jin et al, Cell link
Apr 12, 2025 — The Forgotten Cancer Cure Hiding in Plain Sight: How DMSO turns a common dye into a highly potent cancer treatment that's harmless to normal tissue; “DMSO is a safe and naturally occurring substance that is remarkably effective for a wide range of diseases including pain, injuries, and strokes. DMSO effectively dissolves a variety of medications and can transport them throughout the body. This increases their potency, makes it possible to administer them through the skin, and allows them to target things deep within the body (e.g., resistant infections) that other therapies have difficulty reaching. Through various mechanisms, DMSO selectively targets cancer cells and simultaneously mitigates the consequences of cancer therapies. It also brings conventional and natural cancer therapies to tumors, thereby significantly increasing the potency of these therapies (while simultaneously allowing a much lower and less toxic dose to be used). When DMSO is combined with hematoxylin (a dye widely used in pathology), it becomes a highly potent cancer treatment, both harnessing DMSO’s intrinsic anticancer properties and directly destroying cancer cells. It is also highly specific to targeting cancers while not affecting normal cells, thereby allowing it to dissolve cancers at doses that have virtually no toxicity to the patient.” — A Midwestern Doctor link
Apr 7, 2025 — This Week with Dr. T, with special guest, Dr. Orlando E. Silva; “Dr. Silva has extensive knowledge of insulin potentiation therapy (IPT)—a treatment that uses insulin to increase the effectiveness of chemotherapy while reducing toxic side effects.” — Dr. Sherri Tenpenny link
Apr 4, 2025 — Beta-Glucans — Nature’s Immune Booster You Need to Know About;
